Aspen Aerogels Q1 2024 GAAP EPS $(0.02) Beats $(0.11) Estimate, Sales $94.501M Beat $75.004M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aspen Aerogels (NYSE:ASPN) reported Q1 2024 earnings with a GAAP EPS of $(0.02), surpassing the $(0.11) estimate, and sales of $94.501M, exceeding the $75.004M estimate. This represents significant improvements over the previous year, with a 91.67% increase in EPS and a 107.30% increase in sales.
May 01, 2024 | 9:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aspen Aerogels reported a significant beat on both EPS and sales estimates for Q1 2024, showing strong year-over-year growth.
Aspen Aerogels' earnings beat and significant sales growth indicate a strong financial performance and operational efficiency, likely leading to positive investor sentiment and potential stock price appreciation in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100